K. Theunissen

发表

A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay.

C. Verfaillie, K. Theunissen, 2005, Experimental hematology.

A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis

G. Perrotta, O. Deryck, B. Dubois, 2018, Acta Neurologica Belgica.

Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.

G. Verhoef, M. Delforge, K. Theunissen, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis

D. Niederwieser, M. McMullin, C. Harrison, 2015, Experimental Hematology & Oncology.

Myelofibrosis patients in Belgium: disease characteristics

L. Knoops, Z. Berneman, W. Pluymers, 2015, Acta clinica Belgica.

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.

M. André, K. van Eygen, W. Pluymers, 2014, Leukemia research.

Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients

P. Vermeersch, M. Hoenigl, P. Annaert, 2016, European Journal of Clinical Pharmacology.

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.

G. Verhoef, A. Wilmer, J. Verhaegen, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders

K. Theunissen, K. Lagrou, J. Maertens, 2007, Mycoses.

Defining a case of invasive aspergillosis by serum galactomannan.

D. Deeren, K. Theunissen, J. van Eldere, 2006, Medical mycology.

Preemptive antifungal therapy: still a way to go

D. Deeren, K. Theunissen, D. Dierickx, 2006, Current opinion in infectious diseases.

Key-interventions derived from three evidence based guidelines for management and follow-up of patients with HFE haemochromatosis

D. Swinkels, H. Van Vlierberghe, C. Mathieu, 2014, BMC Health Services Research.

Bone marrow cell transfer in acute myocardial infarction

S. Janssens, F. Werf, M. Boogaerts, 2006, Nature Clinical Practice Cardiovascular Medicine.

Adult umbilical cord blood transplantation: a comprehensive review

J. Wagner, C. Verfaillie, M. Boogaerts, 2006, Bone Marrow Transplantation.

Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.

G. Verhoef, E. Verbeken, K. Theunissen, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prospective clinical evaluation of lower cut‐offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients

J. Verhaegen, M. Boogaerts, E. Verbeken, 2004, British journal of haematology.

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantati

H. Einsele, G. Mufti, A. Hunter, 2006, Blood.

Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation.

H. Einsele, R. Martino, C. Cordonnier, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

False-positive Aspergillus galactomannan antigen test results.

G. Verhoef, K. Theunissen, J. van Eldere, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Non-Hodgkin Lymphoma after Treatment with Extended Dosing Temozolomide and Radiotherapy for a Glioblastoma: A Case Report

R. Achten, K. Theunissen, R. Drijkoningen, 2013, Case Reports in Oncology.

Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients

K. Theunissen, J. Maertens, G. Huysmans, 2008, Current infectious disease reports.

Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey

V. Voelter, D. Deeren, K. Theunissen, 2015, Acta clinica Belgica.

Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes , acute myeloid leukaemia , or chronic myelomonocytic leukaemia : results of a real-life , non-interventional postmarketing survey

V. Voelter, D. Deeren, K. Theunissen, 2015 .

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

J. Esteve, K. Döhner, H. Döhner, 2021, HemaSphere.

PHASE III RANDOMIZED TRIAL OF VOLASERTIB PLUS LOW-DOSE CYTARABINE (LDAC) VERSUS PLACEBO PLUS LDAC IN PATIENTS AGED >= 65 YEARS WITH PREVIOUSLY UNTREATED AML, INELIGIBLE FOR INTENSIVE THERAPY

J. Esteve, K. Döhner, H. Döhner, 2016 .

Integrin engagement-induced inhibition of human myelopoiesis is mediated by proline-rich tyrosine kinase 2 gene products.

C. Verfaillie, D. Deyle, K. Theunissen, 2004, Experimental hematology.

Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells.

P. Carmeliet, C. Verfaillie, L. Moons, 2009, The Journal of clinical investigation.

ThemechanismsofBMhematopoieticstem/progenitorcell(HSPC)adhesion,engraftment,andmobilization remainincompletelyidentified.Here,usingWTandtransgenicmice,wehaveshownthatmembrane-anchored plasminogenactivator,urokinasereceptor( M uPAR)marksasubsetofHSPCsandpromotesthepreserva- tionofthesizeofthispoolofc

P. Carmeliet, C. Verfaillie, L. Moons, 2009 .

Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey

L. Knoops, K. van Eygen, W. Pluymers, 2018, European journal of haematology.

Pre-emptive antifungal therapy in neutropenic onco-hematology patients 2007

K. Theunissen, K. Lagrou, J. Maertens, 2007 .

STATE OF THE ART STAMCELTRANSPLANTATIES: FEITEN EN MYTHEN 1

G. Verhoef, A. Uyttebroeck, M. Delforge, 2004 .

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry

K. van Eygen, D. Deeren, V. Havelange, 2021, Annals of Hematology.

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

S. Dymarkowski, J. Bogaert, J. Nuyts, 2006, The Lancet.

Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity

K. Theunissen, K. Lagrou, W. Meersseman, 2012, Journal of Clinical Microbiology.

Reply to Rijnders and Slobbe and to Donnelly and Leeflang

K. Theunissen, K. Lagrou, J. Maertens, 2010 .

Table 1. Characteristics of 29 Patients with Proven Invasive Pulmonary Aspergillosis and Paired Bronchoalveolar Lavage (BAL) Fluid and Serum Galactomannan (GM) Enzyme Immunoassay Results

K. Theunissen, K. Lagrou, J. Maertens, 2010 .

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

G. Verhoef, E. Verbeken, K. Theunissen, 2009, Cancer.

Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata.

E. Verbeken, K. Theunissen, J. van Eldere, 2005, Journal of medical microbiology.

Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay.

J. Donnelly, K. Theunissen, J. van Eldere, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxis

D. Andes, K. Theunissen, R. ter Heine, 2018, The Journal of antimicrobial chemotherapy.

Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.

D. Parenti, A. Elmaagacli, K. van Besien, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

H. Einsele, S. Iacobelli, A. Tomaszewska, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Caphosol in prevention of oral mucositis in autologous stem cell transplant recipients after high-dose melphalan (CASH)

O. Visser, K. Theunissen, J. Maertens, 2012 .

Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study.

Piet Claus, Bart Bijnens, Maria Kalantzi, 2008, European heart journal.

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

G. Papanicolaou, J. Mehta, J. Panse, 2018, The Lancet.

Growth factors and DLI in adult haploidentical transplant: a three-step pilot study towards patient and disease status adjusted management.

P. Martiat, L. Lagneaux, K. Theunissen, 2004, Blood cells, molecules & diseases.

The Dynamics of Nucleotide Variants in the Progression from Low–Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach

N. Bolli, L. Linsen, E. Geerdens, 2022, Cancers.

Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products.

C. Voermans, I. Slaper-Cortenbach, W. Fibbe, 2008, Cytotherapy.

Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning

F. Baron, T. Kerre, K. Theunissen, 2012 .

Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society

F. Baron, T. Kerre, K. Theunissen, 2014, Journal of Hematology & Oncology.

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

F. Baron, T. Kerre, K. Theunissen, 2014 .

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres

D. Deeren, T. Kerre, K. Theunissen, 2019, Bone Marrow Transplantation.

Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium

Z. Berneman, G. Verhoef, K. van Eygen, 2019, Acta Haematologica.

Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients

P. Vermeersch, M. Hoenigl, P. Annaert, 2016, European Journal of Clinical Pharmacology.

Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a randomized placebo-controlled trial (ZOE-HSCT).

K. Sullivan, J. Szer, M. Dickinson, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Targeted next‐generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics

N. Put, R. Achten, K. Theunissen, 2017, International journal of laboratory hematology.

Acute autonomic dysregulation due to HHV-6 encephalitis in an immunocompromised patient: a case report and literature review

K. Theunissen, Koen Delmotte, Inge Indesteege, 2022, Acta Neurologica Belgica.

Reply to Stefani et al

K. Theunissen, K. Lagrou, J. Maertens, 2006 .

Transplantation of autologous bone marrow-derived stem cells in patients with ST-segment elevation myocardial infarction

S. Dymarkowski, J. Bogaert, J. Nuyts, 2005 .